← FDA Warning Letters

PharmaCanna

FDA Warning Letter · 2023-01-06 · Center for Drug Evaluation and Research | CDER

Letter

Company
PharmaCanna
Posted Date
2023-01-06
Letter Issue Date
2023-01-05
Issuing Office
Center for Drug Evaluation and Research | CDER

Subject

Unapproved and Misbranded Products Related to Coronavirus Disease 2019 (COVID-19)

Source

Authoritative
FDA Warning Letters
Machine
JSON-LD · Markdown